7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,592.03

+550.64

+0.71%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

OTC Markets OTCPK - Delayed Quote USD

Ondine Biomedical Inc. (OBIMF)

0.2200 0.0000 (0.00%)

At close: October 30 at 4:00:00 PM EDT

Loading Chart for OBIMF

Chart Range Bar

Interval:

In partnership with ChartIQ

Ondine reports negligible adverse event rate for nasal light therapy in 5,188-patient trial - UPDATE

Ondine reports negligible adverse event rate for nasal light therapy in 5,188-patient trial - UPDATE

Ondine Biomedical says Canadian hospital findings reinforces Steriwave's point of care value - UPDATE

Ondine Biomedical says Canadian hospital findings reinforces Steriwave's point of care value - UPDATE

Ondine Biomedical fundraise gives runway into 2028 as NDA submission moves closer

Ondine Biomedical fundraise gives runway into 2028 as NDA submission moves closer

Ondine Biomedical raises £10m for international commercial expansion

Ondine Biomedical raises £10m for international commercial expansion

Ondine Biomedical pauses trading to raise fresh investment after positive phase III result

Ondine Biomedical pauses trading to raise fresh investment after positive phase III result

Ondine shares backed by Peel Hunt as NHS ICU access expands

Ondine shares backed by Peel Hunt as NHS ICU access expands

Ondine Biomedical taps NHS intensive care data to prove Steriwave pays its way

Ondine Biomedical taps NHS intensive care data to prove Steriwave pays its way

Ondine wins five Ontario hospitals for Steriwave infection treatment

Ondine wins five Ontario hospitals for Steriwave infection treatment

Ondine Biomedical gains 5% as LANTERN clears phase III hurdle

Ondine Biomedical gains 5% as LANTERN clears phase III hurdle

Ondine Biomedical strikes deal with Mexico's largest private hospital network

Ondine Biomedical strikes deal with Mexico's largest private hospital network

Ondine Biomedical shares rise 8% as ICU study shows nasal photodisinfection cuts pneumonia rates by nearly 40%

Ondine Biomedical shares rise 8% as ICU study shows nasal photodisinfection cuts pneumonia rates by nearly 40%

Mobilize your Website

View Site in Mobile | Classic

Share by: